arrow
L

Laura Porretti

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
H指数:34
被引数:3,627

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation
2026-01-190
OAAI
Corrigendum to “iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis” [Mucosal Immunol. 16(3) (2023) 326–340
2025-12-110
OAAI
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis
2024-07-260
OAAI
Magnetic-field-driven targeting of exosomes modulates immune and metabolic changes in dystrophic muscle
2024-07-220
OAAI
Incidence, microbiological and immunological characteristics of ventilator-associated pneumonia assessed by bronchoalveolar lavage and endotracheal aspirate in a prospective cohort of COVID-19 patients: CoV-AP study
2023-09-263
OAAI
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis

iNKT细胞-中性粒细胞串扰促进结直肠癌发病机制

2023-06-017
OAAI
IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T Lymphocytes
2022-03-3111
OAAI
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis

在HDV相关肝硬化患者中长达3年的布列维肽单药治疗的安全性和有效性

2022-02-0151
PRE
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes
2020-12-0940
OAAI
Late-onset and long-lasting autoimmune neutropenia: an analysis from the Italian Neutropenia Registry
2020-11-1820
OAAI
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease

阿尔茨海默病患者血浆神经源性小胞外囊泡MiRNA表达谱研究

CELLS
IF5.2
2020-06-1086
OAAI
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients

高剂量myrcludex-b单药治疗48周HDV相关代偿期肝硬化的良好安全性和有效性: 3例患者的病例报告

2019-10-0154
PREAI